Navigation Links
GE Medical Systems Signs Clinical Trial with National Cancer Institute

By using agents like FLT that can specifically image proliferation and other aspects of tumor biology, we can look at tumors before and soon after treatment to determine reliably whether a given therapy will be effective or not," Thrall said. "The idea is to personalize therapy by using PET imaging of the cancer to choose the right treatment and enable the patient to avoid inappropriate therapy." ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 11/24/03


Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Medical College team creates website for tracking flu
3. Medical College receives $1.4M cancer grant
4. Medical technology firm lands $100K federal grant
5. Doyle outlines spending for Medical College, UWM
6. Medical College lands $8.1M grant to detect bird flu, bioterror agents
7. Medical College dedicates $140M research facility
8. Dunn to step down as Medical College dean
9. Medical College team seeks stem cell patent
10. Medical College part of $5M cancer study
11. Medical College secures $9.7M research grant
Post Your Comments:
Breaking Biology News(10 mins):Breakthrough in monitoring tropical deforestation announced in Copenhagen 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Pathological gambling may be successfully treated with medications for substance addiction 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 1Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 2Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 4Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 5Service Dogs Help Traumatized Veterans Heal 56119 1Service Dogs Help Traumatized Veterans Heal 56119 2Service Dogs Help Traumatized Veterans Heal 56119 3